An Open-Label Multicentre Long-Term Extension Study of Etanercept in Ankylosing Spondylitis
An Open-Label Multicentre Long-Term Extension Study of Etanercept in Ankylosing Spondylitis
This study is an extension trial of 0881A3-312-EU and is designed to provide information on the safety and efficacy of etanercept in patients with ankylosing spondylitis for up to 3 additional years.
Inclusion Criteria:
Exclusion Criteria: